Opinion: Restore a better balance to public-private funding of biomedical research
The pharmaceutical industry says that if the U.S. reduces the astronomical drug prices paid by U.S. consumers, lifesaving innovation will be devastated.
That’s not true. There are ways for the U.S. to reduce drug prices while maintaining and perhaps even accelerating its innovation engine.
